Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Cardiology
•
Interventional Cardiology
•
Hospital Medicine
Following left main bifurcation stenting, do you routinely proceed with kissing balloon inflation of the side branch, either LCx or LAD?
Answer from: at Community Practice
It depends on the technique used; most crush based techniques require kissing balloon inflation.
Comments
at The George Washington University Hospital
Routinely, yes.
14471
Sign In
or
Register
to read more
Answer from: at Community Practice
Simple answer, yes. Complexities exist that could modify the approach, but in general, ensuring the bifurcation is maximally dilated is my preferred technique.
Sign In
or
Register
to read more
Answer from: at Academic Institution
Yes
Sign In
or
Register
to read more
Answer from: at Community Practice
It is ideal to do it. Sometimes, however, it may not be feasible.
Sign In
or
Register
to read more
Answer from: at Community Practice
Most of the time but again depends on lesson and which technique I used.
Sign In
or
Register
to read more
Answer from: at Community Practice
Ideally, yes.
Sign In
or
Register
to read more
Answer from: at Community Practice
The answer is yes. One must do kissing balloons after complex LM bifurcation stenting unless it is technically not possible.
Sign In
or
Register
to read more
20782
20992
21415
21488
21483
22325
26106
Related Questions
Do you pursue stress testing before discharge for a patient admitted with chest pain who has negative serial high-sensitivity troponins and a low HEART score?
How do you decide when you pursue inpatient right heart catheterization in patients with CT or TTE findings suggestive of underlying pulmonary hypertension?
When you identify new atrial fibrillation in a hospitalized patient that spontaneously converts to sinus rhythm within 24–48 hours, and the patient has a CHA₂DS₂-VASc score of 2–3, how do you decide whether to initiate anticoagulation and/or discharge with a wearable cardiac monitor?
How soon after an acute upper GI bleed do you restart therapeutic anticoagulation in a patient with atrial fibrillation and a high thromboembolic risk (CHA₂DS₂-VASc ≥4)?
When do you add a thiazide-type diuretic to IV furosemide for a patient with acute decompensated heart failure who has had an inadequate diuretic response after 48 hours?
What is your approach to treating patients with decompensated heart failure when their hypervolemia is refractory to oral furosemide?
When would you consider switching to or adding on a PCSK9 inhibitor to lipid-lowering therapy following hospital discharge for acute coronary syndrome, in light of the results of the VICTORION-INCEPTION trial, provided LDL is still not at goal?
In light of recent data suggesting that potassium-enriched salt substitution reduces cardiovascular events, have you reconsidered implementing specialized diets for hospitalized patients with hypertension or heart failure?
What neurologic and hemodynamic parameters do you use to determine candidacy for emergent cath lab activation following out of hospital cardiac arrest from VT/VF in patients with NSTEMI after ROSC has been achieved?
For older adults undergoing intermediate-risk non-cardiac surgery, do you routinely check pre-operative pro-BNP levels for risk stratification based on emerging data and updated Canadian guidelines?
Routinely, yes.